Static Chart Molecure S.A.

Equities

Market Closed - Warsaw S.E. Other stock markets 16:55:41 03/06/2024 BST			5-day change	1st Jan Change
15.26 ^PLN	+2.28%		+0.53%	-21.74%

05-21	Molecure S.A. Receives Approval to Initiate A Phase II Clinical Trial for OATD-01 for the Treatment of Pulmonary Sarcoidosis in Selected Countries of the European Union and Norway	CI
05-17	Molecure S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Duration

Period